Literature DB >> 11454428

Chromosomal aberrations in Bloom syndrome patients with myeloid malignancies.

B Poppe1, H Van Limbergen, N Van Roy, E Vandecruys, A De Paepe, Y Benoit, F Speleman.   

Abstract

Bloom syndrome (BS) predisposes affected individuals to a wide variety of neoplasms including hematological malignancies. Thus far, cytogenetic findings in hematological neoplasms have been reported in only a few BS patients. We present the karyotypic findings in a BS patient diagnosed with acute myeloid leukemia (AML), FAB subtype M1, and a review of the literature, showing the preferential occurrence of total or partial loss of chromosome 7 in BS patients with AML or myelodysplastic syndromes (MDS).

Entities:  

Mesh:

Year:  2001        PMID: 11454428     DOI: 10.1016/s0165-4608(01)00392-2

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  13 in total

1.  Control of translocations between highly diverged genes by Sgs1, the Saccharomyces cerevisiae homolog of the Bloom's syndrome protein.

Authors:  Kristina H Schmidt; Joann Wu; Richard D Kolodner
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

2.  Mutation of the murine Bloom's syndrome gene produces global genome destabilization.

Authors:  Nicholas Chester; Holger Babbe; Jan Pinkas; Charlene Manning; Philip Leder
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

3.  BLAP75, an essential component of Bloom's syndrome protein complexes that maintain genome integrity.

Authors:  Jinhu Yin; Alexandra Sobeck; Chang Xu; Amom Ruhikanta Meetei; Maureen Hoatlin; Lei Li; Weidong Wang
Journal:  EMBO J       Date:  2005-03-17       Impact factor: 11.598

Review 4.  DNA damage accumulation and repair defects in acute myeloid leukemia: implications for pathogenesis, disease progression, and chemotherapy resistance.

Authors:  Maria Teresa Esposito; Chi Wai Eric So
Journal:  Chromosoma       Date:  2014-08-12       Impact factor: 4.316

5.  Mice heterozygous for CREB binding protein are hypersensitive to γ-radiation and invariably develop myelodysplastic/myeloproliferative neoplasm.

Authors:  Stephanie N Zimmer; Madeleine E Lemieux; Bijal P Karia; Claudia Day; Ting Zhou; Qing Zhou; Andrew L Kung; Uthra Suresh; Yidong Chen; Marsha C Kinney; Alexander J R Bishop; Vivienne I Rebel
Journal:  Exp Hematol       Date:  2011-12-20       Impact factor: 3.084

Review 6.  Role of chromosomal aberrations in clonal diversity and progression of acute myeloid leukemia.

Authors:  T Bochtler; S Fröhling; A Krämer
Journal:  Leukemia       Date:  2015-02-12       Impact factor: 11.528

Review 7.  Epidemiology of childhood acute myeloid leukemia.

Authors:  Susan E Puumala; Julie A Ross; Richard Aplenc; Logan G Spector
Journal:  Pediatr Blood Cancer       Date:  2013-01-09       Impact factor: 3.167

Review 8.  Myelodysplastic syndrome: an inability to appropriately respond to damaged DNA?

Authors:  Ting Zhou; Paul Hasty; Christi A Walter; Alexander J R Bishop; Linda M Scott; Vivienne I Rebel
Journal:  Exp Hematol       Date:  2013-04-30       Impact factor: 3.084

Review 9.  RecQ helicases: suppressors of tumorigenesis and premature aging.

Authors:  Csanád Z Bachrati; Ian D Hickson
Journal:  Biochem J       Date:  2003-09-15       Impact factor: 3.857

10.  Acute myeloid leukaemia after treatment for acute lymphoblastic leukaemia in girl with Bloom syndrome.

Authors:  Madeleine Adams; Meriel Jenney; Laz Lazarou; Rhian White; Sanda Birdsall; Timo Staab; Detlev Schindler; Stefan Meyer
Journal:  J Genet Syndr Gene Ther       Date:  2013-09-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.